Johnson & Johnson Charges for acquired in-process research and development assets decreased by 88.2% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 87.5%, from $16.00M to $2.00M.
operating_in_process_research_and_development_charge| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $1.25B | $16.00M | $76.00M | $17.00M | $2.00M |
| QoQ Change | — | — | — | -98.7% | +375.0% | -77.6% | -88.2% |
| YoY Change | — | — | — | — | — | -98.6% | -87.5% |